Patient with major depressive disorder and anxiety, currently taking bupropion XL 450 mg daily, gabapentin 600 mg three times daily, quetiapine 50 mg three times daily, and as‑needed hydroxyzine, can buspirone be added?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Buspirone Be Added to This Regimen?

Yes, buspirone can be added to this patient's current regimen for ongoing anxiety symptoms, but with important caveats regarding the bupropion dose and monitoring requirements.

Key Considerations

Bupropion Dose Concern

Your patient is on bupropion XL 450 mg daily, which is at the maximum FDA-approved dose. The FDA label warns that bupropion should not be used in agitated patients 1. While this patient has anxiety rather than agitation, the high dose warrants caution. Consider reducing bupropion to 300 mg daily before adding buspirone, as this may help manage anxiety without additional medication and reduces seizure risk.

Buspirone as Augmentation Strategy

Buspirone has demonstrated efficacy for augmenting antidepressants in treatment-resistant depression with anxiety:

  • In patients with severe depression (MADRS >30) who failed SSRI monotherapy, buspirone augmentation produced significantly greater improvement than placebo (p=0.026) 2
  • 59% of patients showed complete or partial remission when buspirone was added to SSRIs 3
  • Buspirone augmentation showed comparable efficacy to bupropion augmentation in second-step treatment strategies 4

However, buspirone may delay response time: One study found that fluoxetine plus buspirone had slower onset (40 days) compared to fluoxetine alone (24-33 days) 5. This suggests buspirone works best as augmentation after adequate antidepressant trials, not as initial combination therapy.

Dosing Protocol

Start low and titrate slowly:

  • Initial dose: 5 mg twice daily 6
  • Titrate by 5 mg every 3-7 days as tolerated
  • Target dose: 20-30 mg daily in divided doses (typically 10-15 mg BID) 2, 3
  • Maximum dose: 60 mg daily (20 mg TID) 6, 7

Critical timing consideration: Buspirone requires 2-4 weeks to become effective 6. Set appropriate expectations with the patient.

Drug Interactions and Safety

No major contraindications exist with current medications:

  • Buspirone does not significantly interact with bupropion, gabapentin, quetiapine, or hydroxyzine
  • Avoid MAOIs (not applicable here) 7
  • Monitor for serotonin syndrome if combining with serotonergic agents, though risk is low with this regimen 8

The FDA label notes buspirone may displace protein-bound drugs like digoxin 7, but this is not relevant to your patient's current medications.

Monitoring Requirements

Monitor for:

  • Blood pressure: Bupropion can cause hypertension (2% incidence), and adding buspirone requires BP monitoring 1
  • Dizziness and sedation: Common with buspirone, especially during titration 7
  • Nausea: Reported in buspirone trials 9
  • Response to therapy: Assess at 4 weeks minimum, as buspirone has delayed onset 6

Alternative Consideration

Before adding buspirone, consider optimizing the current regimen:

  1. Reduce bupropion from 450 mg to 300 mg: The 450 mg dose may be contributing to anxiety, as bupropion has stimulating properties and is contraindicated in agitated patients 1. Recent evidence suggests bupropion can provoke anxiety at higher doses 10

  2. Optimize quetiapine dosing: The patient is on 50 mg TID (150 mg total daily). This is a low dose that may provide some anxiolytic benefit but could be optimized

  3. If anxiety persists after bupropion reduction, then add buspirone starting at 5 mg BID

Evidence Quality Note

The evidence for buspirone augmentation comes primarily from studies in SSRI-refractory depression 2, 3, not specifically bupropion combinations. However, systematic reviews show buspirone augmentation has similar efficacy to bupropion augmentation as a second-step strategy 4, suggesting it's a reasonable option.

The strongest evidence supports buspirone for patients with severe depression and anxiety symptoms who have failed initial antidepressant trials 2. Your patient fits this profile with ongoing anxiety despite multiple medications.

Common Pitfalls to Avoid

  • Don't expect immediate results: Buspirone takes 2-4 weeks to work 6
  • Don't start at high doses: Begin at 5 mg BID to minimize dizziness and sedation 7
  • Don't ignore the bupropion dose: 450 mg may be exacerbating anxiety 1, 10
  • Don't combine with MAOIs: Contraindicated due to serotonin syndrome risk 7

Related Questions

In a patient with depression and anxiety who reports lack of motivation and inability to complete tasks while taking bupropion 75 mg daily and buspirone 5 mg twice daily, what medication adjustment should be made?
I have depression and anxiety and am taking escitalopram (Lexapro) and buspirone (Buspar); I am still experiencing anxiety—what adjustments should be made?
A 40-year-old female with a history of depression and anxiety is currently taking Wellbutrin (bupropion) XL 300 mg once daily, Buspar (buspirone) 15 mg twice daily, and sertraline 50 mg once daily. What medication recommendations are appropriate?
What is the appropriate initiation, titration, and monitoring plan for bupropion maintenance therapy in a 27-year-old woman with mixed anxiety and depressive disorder?
In a 59-year-old female nursing-home resident with depression, anxiety, and a history of alcohol abuse who is taking bupropion XL (bupropion) 300 mg daily, escitalopram 20 mg daily, trazodone 100 mg at bedtime and 25 mg in the morning, amphetamine/dextroamphetamine (Adderall) 10 mg daily, and divalproex sodium (Depakote) 250 mg twice daily, and who now presents with worsening depression, social isolation, increased daytime sleepiness, and anhedonia, what is the optimal psychotropic treatment approach?
A patient on testosterone therapy was discontinued because the prostate-specific antigen (PSA) was 30 ng/mL; if the subsequent PSA is 15 ng/mL, what are the recommended next steps?
Is a marker‑ball (fiducial) radiograph used for Mako robotic‑assisted total hip arthroplasty or for conventional total hip replacement?
Is fexofenadine included on the Beers Criteria list of medications to avoid in older adults?
When should an oral glucose tolerance test be performed to screen for gestational diabetes mellitus in a 29-year-old pregnant woman at 12 weeks gestation with no prior diabetes or risk factors?
I am taking bupropion and experiencing tinnitus; is this a known side effect and what steps should I take to address the ear ringing?
What is the appropriate treatment for a healthy 4-year-old child with a rash?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.